Introduction
Tropical endomyocardial disease became widely known after its description in Uganda (Davies, 1948) . Subsequent work there clarified the clinical and pathological features of the disorder, and it was classified as a distinct cardiomyopathy (Patel, D'Arbela and Somers, 1977) . However, the presence of an eosinophilia in many of these patients, especially those living in areas of endemic filariasis, raised the possibility that tropical endomyocardial disease had a similar pathogenesis to eosinophilic endomyocardial disease, which is mainly seen in temperate climates (Gerbaux et al., 1956; Ive. Willis and Ikeme, 1967) . This led Brockington and Olsen (1973) to carry out a review of pathological specimens of late stage (fibrotic) endomyocardial disease which had been recognised in tropical and temperate regions. They found that the lesions were indistinguishable.
During the past 7 years we have been studying patients in the United Kingdom (U.K.) with eosinophilic endomyocardial disease which occurs as one complication of the hypereosinophilic syndrome . Clinical and experimental studies supported the suggestion that this form of endomyocardial disease was related to the presence of large numbers of eosinophils in the blood, particularly degranulated eosinophils. It is proposed that the granule products from these cells cause the endomyocardial lesions (Spry, Tai and Davies, 1983) .
Although it was felt that both tropical and eosinophilic endomyocardial disease could have a similar pathogenesis (Olsen and Spry, 1979) , it became necessary to explain why a number of differences had been reported. For this reason it was decided to carry out a study of these forms of endomyocardial disease in the U.K. and tropics, to compare the clinical and cardiological features of endomyocardial disease in these regions. Unfortunately, this could not be done in Uganda, so two other tropical regions with a high incidence of tropical endomyocardial fibrosis were chosen: Kerala (South India) and Bahia (Brazil).
Patients
The 11 patients in the U.K. with eosinophilic endomyocardial disease have been described previously . They all had biventricular endomyocardial disease. Nine had marked mitral valve disease, and 6 had severe tricuspid regurgitation. Four patients were studied during the early necrotic stage of the disease, and 5 were studied in the late fibrotic stage.
Forty-seven patients were studied in India and 8 patients in Brazil. These patients all had clinical and cardiological features of advanced endomyocardial *disease in the late fibrotic stage.
Results
A summary of the general and cardiovascular features of patients with endomyocardial disease in the temperate region and the two tropical regions is shown in Fig. 1 and 2 .
A number of important differences were found. Many patients living in the U.K. were in their fourth decade (mean age 38 years) and 9 were male. Half of them presented in the early necrotic stage of the disease. They all had a systemic illness with hypereosinophilia, the hypereosinophilic syndrome. This syndrome is associated with wide-spread tissue injury including the heart (eosinophilic endomyocardial disease), skin, retina (Chaine et al., 1982) , blood vessels, lymph nodes, spleen, gastrointestinal tract and lungs. On the other hand, patients in the tropical regions were younger (mean age 17 years in India and 30 years in Brazil), and had an equal sex incidence of the disease. They were from the poorest socio-economic groups, with malnutrition and features of chronic growth retardation. They all presented at a late stage of the disease with ascites and/or periorbital oedema. Despite clinical features of advanced cardiac disease, they were remarkably free from severe symptoms, and appeared to have adapted to their restrictive heart failure. This suggested .that heart disease had been present for many years. None of them had suffered from a systemic illness with similarities to the hypereosinophilic syndrome.
Cardiological studies-showed some similarities and some differences in the clinical features of patients with endomyocardial disease from the U.K. and the tropics. Most patients had a loud third heart sound and raised jugular venous pressure. A positive Kussmaul's sign was noted frequently in both groups. However, murmurs of atrio-ventricular valve regur- gitation, particularly mitral regurgitation, were more common in patients in the U.K.; half of the patients in India and Brazil had no cardiac murmurs, even though they all had severe restrictive heart defects. Electrocardiograms showed some differences: in the U.K. there was sinus rhythm with ST depression (Fig. 3) , whereas in India and Brazil atrial fibrillation with right axis deviation was common (Fig. 4) . Echocardiography showed no significant differences between the 2 groups of patients, when staging of the disease was taken into account. Details of the echocardiographic features of eosinophilic endomyocardial disease have already been published . M-mode echocardiography-showed nonspecific changes which did not correlate either with the severity of endomyocardial disease or the thickness of the posterior left ventricular wall. On the other hand, two-dimensional echocardiography, and regional echo amplitude analysis, showed abnormalities corresponding to areas of endomyocardial disease.
Results of haematological studies and immunoglobulin measurements in patients with eosinophilic endomyocardial disease in the U. K reported separately (Brockington and Olsen, 1973) , this study has clearly shown some important regional differences in the clinical presentation, cardiological features and laboratory abnormalities. The principal differences were in the sex incidence and age groups affected, and the absence of isolated left or right ventricular disease in the U.K. However, these studies show no fundamental differences in the nature or characteristics of endomyocardial disease as it affected the heart in either region. For this reason, these differences probably indicate variations in the underlying disease process, which leads to a final common cardiac pathology.
Patients in the U.K. all had one underlying disease: the hypereosinophilic syndrome. This did not appear to have been present in any of the patients studied in India or Brazil, and none had a preceding history suggesting that they had some variant of this syndrome. However, as there is strong clinical and experimental evidence to suggest that eosinophils themselves are involved in the development of eosinophilic endomyocardial disease (Spry, Tai and Davies, 1983) , it is important to consider whether eosinophils might also have been involved in the development of tropical endomyocardial disease. Most of the Indian and Brazilian patients had an eosinophilia, even though they were in the late fibrotic stage of the disease. They came from poor socio-economic groups and had a higher incidence of parasitic diseases. 
